Eli Lilly's revenue rises 5 percent as diabetes drugs gain savita thakur thakur30 Jan 2016 11:44 AM ISTDrugmaker Eli Lilly and Co reported a 5 percent rise in quarterly revenue, helped by increased sales of its diabetes drugs and higher volume.The...
Europe recommends lung cancer drugs from AstraZeneca, Lilly savita thakur thakur19 Dec 2015 11:41 AM ISTThe European Medicines Agency said  its experts had recommended marketing approval for lung cancer drugs developed by AstraZeneca and Eli Lilly and...
FDA approves Portrazza to treat advanced squamous non-small cell lung cancer savita thakur thakur3 Dec 2015 3:02 PM ISTThe U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced...
US agencies investigate Merck, Lilly drug pricing Meghna A Singhania8 Nov 2015 11:25 AM ISTU.S. drugmakers Merck & Co and Eli Lilly & Co are being investigated by federal prosecutors over their drug-pricing practices, the companies...
Lilly diabetes drug slashes deaths in patients with heart risk Meghna A Singhania20 Sept 2015 1:05 PM ISTEli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack and stroke, a finding that...
Diabetes Drug Jardiance may also reduce risk of heart attacks, strokes and CVD Meghna A Singhania23 Aug 2015 6:33 AM ISTTRENTON, N.J. - For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer...
